1 hour ago · DR Congo
Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain
What's happening
SignalsMonitor is following this as a health story. Times of India World is the outlet attached so far. The reports are tied to DR Congo. The first report grouped here was at 24 Oct 2026, 03:09 UTC. The headline in use is “Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
In a historic move, the World Health Organization has launched its inaugural clinical trial for an Ebola vaccine in the Democratic Republic of Congo. This trial aims to assess the efficacy of the Ervebo vaccine against the Bundibugyo virus amid a severe outbreak that has resulted in over 9,700 cases…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Times of India World
Reported by 1 outlet
- Times of India